Context Therapeutics Inc (CNTX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

As of close of business last night, Context Therapeutics Inc’s stock clocked out at $1.83, up 1.10% from its previous closing price of $1.81. In other words, the price has increased by $1.10 from its previous closing price. On the day, 0.6 million shares were traded. CNTX stock price reached its highest trading level at $2.0099 during the session, while it also had its lowest trading level at $1.76.


To gain a deeper understanding of CNTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.23 and its Current Ratio is at 4.23. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTX now has a Market Capitalization of 29217964 and an Enterprise Value of 14448729.

Stock Price History:

The Beta on a monthly basis for CNTX is 2.22, which has changed by 2.1153183 over the last 52 weeks, in comparison to a change of 0.25590587 over the same period for the S&P500. Over the past 52 weeks, CNTX has reached a high of $1.88, while it has fallen to a 52-week low of $0.47. The 50-Day Moving Average of the stock is 38.28%, while the 200-Day Moving Average is calculated to be 60.45%.

Shares Statistics:

It appears that CNTX traded 523.46K shares on average per day over the past three months and 2909310 shares per day over the past ten days. A total of 15.97M shares are outstanding, with a floating share count of 14.04M. Insiders hold about 12.06% of the company’s shares, while institutions hold 17.16% stake in the company. Shares short for CNTX as of 1713139200 were 40409 with a Short Ratio of 0.08, compared to 1710460800 on 17003. Therefore, it implies a Short% of Shares Outstanding of 40409 and a Short% of Float of 0.27.

Earnings Estimates

The performance of Context Therapeutics Inc (CNTX) in the stock market is under the watchful eye of 1 analysts actively contributing to its current rating.On average, analysts expect EPS of -$0.44 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.44, while EPS last year was -$0.37. The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.13 and low estimates of -$0.13.

Analysts are recommending an EPS of between -$0.76 and -$1.36 for the fiscal current year, implying an average EPS of -$1.06. EPS for the following year is -$0.61, with 1.0 analysts recommending between -$0.61 and -$0.61.

Most Popular

[the_ad id="945"]